Hepaxane 2000 IE/UI (20 mg)/0.2 ml
Hepaxane 2000 IE/UI (20 mg)/0.2 ml is a medicine authorised by Swissmedic under authorisation number 67702. The authorisation holder is EFFIK SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 August 2021 and the authorisation is valid without a time limit. ATC code B01AB05 places the medicine in the group Antithrombotic agents.
| Authorisation number | 67702 |
|---|---|
| Name | Hepaxane 2000 IE/UI (20 mg)/0.2 ml |
| Full name | Hepaxane 2000 IE/UI (20 mg)/0.2 ml, solution injectable en seringue préremplie |
| Authorisation holder | EFFIK SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AB05 |
| First authorisation | 12 August 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Hepaxane 2000 IE/UI (20 mg)/0.2 ml, solution injectable en seringue préremplie | B | 12 August 2021 |
| 2 | Hepaxane 4000 IE/UI (40 mg)/0.4 ml, solution injectable en seringue préremplie | B | 12 August 2021 |
| 3 | Hepaxane 6000 IE/UI (60 mg)/0.6 ml, solution injectable en seringue préremplie | B | 12 August 2021 |
| 4 | Hepaxane 8000 IE/UI (80 mg)/0.8 ml, solution injectable en seringue préremplie | B | 12 August 2021 |
| 5 | Hepaxane 10'000 IE/UI (100 mg)/1 ml, solution injectable en seringue préremplie | B | 12 August 2021 |
| 6 | Hepaxane 12'000 IE/UI (120 mg)/0.8 ml, solution injectable en seringue préremplie | B | 12 August 2021 |
| 7 | Hepaxane 15'000 IE/UI (150 mg)/1 ml, solution injectable en seringue préremplie | B | 12 August 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 8 | 50 (5 x 10) | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 9 | 20 (2 x 10) | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 2 | 10 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 10 | 2 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 11 | 6 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 12 | 20 (2 x 10) | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 13 | 50 (5 x 10) | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 3 | 10 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 14 | 20 (2 x 10) | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 4 | 10 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 5 | 10 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 6 | 10 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
| 7 | 10 | Fertigspritze(n) | B01AB05 | 06.03.3. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Hepaxane 2000 IE/UI (20 mg)/0.2 ml authorised in Switzerland?
Yes. Hepaxane 2000 IE/UI (20 mg)/0.2 ml is authorised by Swissmedic under authorisation number 67702, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Hepaxane 2000 IE/UI (20 mg)/0.2 ml have?
Hepaxane 2000 IE/UI (20 mg)/0.2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Hepaxane 2000 IE/UI (20 mg)/0.2 ml?
The authorisation holder is EFFIK SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.